CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-03-01 | Rieder Wendy E VP, IP and Legal, Gen. Counsel | Grant or award · Employee Stock Option (Right to Buy) | +41,891 | 41,891 | ||
| 2011-03-01 | Ehrlich Keith S VP, Fin. and Admin., CFO | Sale | −2,537 | $5.51 | $14K | 17,573 |
| 2011-03-01 | Ehrlich Keith S VP, Fin. and Admin., CFO | Grant or award | +4,397 | 21,970 | ||
| 2011-03-01 | Ehrlich Keith S VP, Fin. and Admin., CFO | Grant or award · Employee Stock Option (Right to Buy) | +41,891 | 41,891 | ||
| 2011-03-01 | Koya Keizo Sr. VP, Drug Development | Sale | −18,270 | $5.23 | $96K | 32,999 |
| 2011-03-01 | Koya Keizo Sr. VP, Drug Development | Grant or award | +6,844 | 39,843 | ||
| 2011-03-01 | Koya Keizo Sr. VP, Drug Development | Grant or award · Employee Stock Option (Right to Buy) | +58,200 | 58,200 | ||
| 2010-11-29 | Singh Amar Sr. VP, Business & Comm. Dvp. | Grant or award | +25,000 | 25,000 | ||
| 2010-11-29 | Singh Amar Sr. VP, Business & Comm. Dvp. | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2010-11-10 | Kovner Bruce Director | Grant or award | +1,440,923 | $3.47 | $5.0M | 3,325,773 |
| 2010-09-28 | KUFE DONALD W Director | Grant or award · Director Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2010-09-15 | Kovner Bruce Director | Purchase | +24,264 | $3.64 | $88K | 1,884,850 |
| 2010-09-14 | Kovner Bruce Director | Purchase | +38,836 | $3.70 | $144K | 1,860,586 |
| 2010-09-13 | Kovner Bruce Director | Purchase | +36,900 | $3.57 | $132K | 1,821,750 |
| 2010-08-16 | Vukovic Vojo SVP, Chief Medical Officer | Purchase | +2,800 | $2.95 | $8K | 17,621 |
| 2010-08-12 | Vukovic Vojo SVP, Chief Medical Officer | Purchase | +714 | $2.84 | $2K | 14,821 |
| 2010-08-05 | BAILEY MICHAEL P Sr. VP, Chief Comm. Officer | Sale | −4,000 | $3.21 | $13K | 29,627 |
| 2010-07-01 | WILSON ROBERT N Director | Grant or award | +7,722 | 472,399 | ||
| 2010-07-01 | WILSON ROBERT N Director | Grant or award · Director Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2010-07-01 | REARDON WILLIAM S Director | Grant or award | +3,861 | 12,237 |
Page 75 of 82 · 1,629 trades